Hamilton Company

Hamilton Company, doing business as Hamilton Co, A Nevada Corp, manufactures and sells robotic liquid handling workstations, automated laboratory equipment, and associated maintenance and consumables to federal agencies as a prime contractor—99% of its recent awards are primes. The company competes in full-and-open federal procurements without set-asides, positioning itself as a full-sized enterprise in the analytical laboratory equipment market. Hamilton Company is a child entity of Hamilton Technologies LLC, a Reno, Nevada-based for-profit LLC that serves as the parent organization.

Hamilton's federal capability portfolio centers on automated liquid handling systems (STAR, Starlet, Microlab Vantage, and NGS STAR platforms), next-generation sequencing workstations, sample preparation automation, and comprehensive maintenance and repair services. Representative recent prime awards include a $6.4 million firm-fixed-price definitive contract with the Bureau of Medicine and Surgery (Navy) for STARLET liquid handling workstations and services through September 2029; a $3.1 million firm-fixed-price maintenance and service agreement with the CDC for liquid handler support through June 2029; a $2.18 million sole-source maintenance contract with Navy Medicine covering drug testing and diagnostic systems across multiple Naval medical facilities through March 2027; and a landmark $115.1 million firm-fixed-price contract with the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response for COVID-19 manufacturing capacity expansion (February 2022–April 2024, now complete). The company also holds or has held $13.1 million in pipette-tip manufacturing capacity contracts and has supplied equipment to the National Institutes of Health, NIST, USDA, FDA, and Department of Veterans Affairs across research, diagnostic, and clinical laboratory settings.

Customer concentration is spread across 53 distinct federal agencies, though a narrow set anchors the dollar value. The top five customer agencies by potential value account for 18% of combined potential value: the CDC Pittsburgh office (27 awards, $10.5 million), the Navy Bureau of Medicine and Surgery (6 awards, $10.1 million), the Defense Health Agency (10 awards, $4.5 million), the Army Medical Command (9 awards, $2.7 million), and the National Institute on Aging (5 awards, $2.3 million). By award count, the top five customer offices account for 30% of awards: USDA Agricultural Research Service Field Research Implementation (37 awards, $618 thousand), CDC Pittsburgh (27 awards, $10.5 million), CDC Acquisition Services (15 awards, $617 thousand), NIST (12 awards, $1.5 million), and Army RDECOM (12 awards, $896 thousand). The divergence reflects CDC's and Navy's anchor-dollar status versus USDA's high-volume, lower-value ordering pattern. Hamilton places task orders under the Federal Supply Schedule GS24F1220C (5 task orders) and the GSA Multiple Award Schedule (2 task orders); most of its volume moves through standalone purchase orders rather than parent vehicles.

Activity has been variable but sustained: 16 awards in 2022, 14 in 2023, 28 in 2024, 17 in 2025, and 3 through mid-2026. Total portfolio strength stands at 338 prime and sub awards with $170.2 million in combined potential value and $161.8 million obligated (95% of potential). Thirteen awards (combined potential value $3.6 million) reach ultimate completion in the next twenty-four months and face recompete exposure. Hamilton's work breaks down by NAICS: Analytical Laboratory Instrument Manufacturing dominates at 144 awards, followed by maintenance and repair categories at 33 and 19 awards respectively. By PSC, Laboratory Equipment and Supplies (145 awards) and maintenance and repair of instruments (63 awards) account for the bulk of procurement activity.

Subcontract footprint is minimal—only three sub-awards in the source data: a June 2025 MD NET service maintenance sub under Becton, Dickinson and Company for robotic workstation support, a September 2023 liquid-handling capital equipment sub under Netcomm, Inc. for the Center for Serological Sciences Network (SERONET), and a February 2025 grant sub-award under Indiana Department of Health for the Epidemiology and Laboratory Capacity program (CFDA 93.067). Federal grant work is similarly sparse; the source identifies the Indiana Department of Health sub-award as the primary federal grant footprint. Hamilton's business model is prime-contractor-centric, with the vast majority of revenue flowing through direct equipment sales and maintenance contracts to federal laboratories rather than through large prime integrators or consortium vehicles.